Bioresorbable (Resorbable) Polymers

Bioresorbable (Resorbable) Polymers

Global Bioresorbable (Resorbable) Polymers Market to Reach US$2.8 Billion by 2030

The global market for Bioresorbable (Resorbable) Polymers estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Orthopedics Application, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Drug Delivery Application segment is estimated at 10.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$428.3 Million While China is Forecast to Grow at 8.2% CAGR

The Bioresorbable (Resorbable) Polymers market in the U.S. is estimated at US$428.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$429.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Bioresorbable (Resorbable) Polymers Market - Key Trends and Drivers Summarized

What Are Bioresorbable Polymers?

Bioresorbable polymers, also known as resorbable or biodegradable polymers, have revolutionized the medical field, offering materials that can safely break down and be absorbed by the body after fulfilling their purpose. These polymers are engineered to degrade naturally through hydrolysis, enzymatic action, or other biological processes. The key advantage of bioresorbable polymers is their ability to eliminate the need for a second surgery to remove implants, making them highly beneficial in applications like sutures, drug delivery systems, and orthopedic implants. Their use is not limited to the medical field; these materials are also being explored in environmental applications, such as biodegradable packaging, due to their eco-friendly nature. The versatility and biocompatibility of these polymers have positioned them as crucial components in advancing both medical technology and sustainable practices.

How Are Technological Advances Shaping the Bioresorbable Polymers Market?

The bioresorbable polymers market has seen significant growth thanks to continuous technological advancements that enhance the properties and applications of these materials. Research and development efforts are focused on improving the mechanical strength, degradation rates, and biocompatibility of these polymers to meet the specific needs of various medical applications. For instance, new copolymer formulations are being developed to create materials that offer both flexibility and strength, which are essential in load-bearing orthopedic implants. Moreover, advancements in drug delivery systems using bioresorbable polymers have allowed for more controlled and sustained release of therapeutic agents, improving treatment efficacy. The integration of 3D printing technology with bioresorbable polymers has opened new avenues for personalized medicine, enabling the creation of custom-made implants and scaffolds tailored to individual patient needs. These technological strides are not only expanding the applications of bioresorbable polymers but also enhancing their performance in critical medical procedures.

What Role Do End-Use Trends Play in the Adoption of Bioresorbable Polymers?

The adoption of bioresorbable polymers is closely tied to shifting trends in end-use industries, particularly healthcare. As the global population ages, there is a growing demand for advanced medical devices and implants that offer reduced complication rates and faster recovery times. This demand has led to increased adoption of bioresorbable materials in orthopedics, cardiology, and drug delivery systems. Additionally, the rising incidence of chronic diseases and the emphasis on minimally invasive procedures are driving the use of bioresorbable polymers, as these materials support the development of devices that are less invasive and reduce the need for repeat surgeries. Beyond healthcare, there is also a growing interest in bioresorbable polymers within the environmental sector, as industries seek sustainable alternatives to traditional plastics. This trend is particularly evident in the packaging industry, where biodegradable materials are becoming more popular due to consumer demand for eco-friendly products. The convergence of these trends across multiple sectors is significantly boosting the market for bioresorbable polymers.

What’s Fueling the Growth of the Bioresorbable Polymers Market?

The growth in the bioresorbable polymers market is driven by several factors, each playing a crucial role in expanding the demand for these innovative materials. Technological advancements are at the forefront, as continuous improvements in polymer science enhance the performance, reliability, and application range of bioresorbable materials. In the medical sector, the rising need for biocompatible and resorbable materials in devices such as stents, screws, and sutures is a major driver, fueled by the increasing preference for minimally invasive surgical procedures. The push towards sustainability is another significant factor, as both consumers and industries seek environmentally friendly alternatives to conventional plastics. Regulatory support for biodegradable materials, particularly in the healthcare and environmental sectors, is further propelling market growth. Additionally, the increasing R&D investments from both public and private sectors are accelerating the development of new bioresorbable polymers, thereby expanding their commercial viability. Together, these factors are creating a robust growth environment for the bioresorbable polymers market, positioning it as a key player in the future of both healthcare and sustainable materials.

Select Competitors (Total 11 Featured) -

• Advanced Extrusion, Inc.
• Corbion NV
• Foster Corporation
• JSP Corporation.
• MAST Biosurgery AG
• Poly-Med, Inc.
• R3 Vascular Inc.
• REVA Medical, Inc.
• Shandong ThFine Chemical Co., Ltd.
• Teknimed

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.